肝癌患者-话题@MedSci

#肝癌患者#

80篇内容 | 1071人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1969063, encodeId=851619690635a, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Pain：肝癌患者术后阿片类药物使用与长期手术结局并无相关性, objectType=article, longId=738978, objectId=ba6ee38978b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba6ee38978b4, replyNumber=0, likeNumber=49, createdTime=2023-02-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba6ee38978b4, moduleTitle=Pain：肝癌患者术后阿片类药物使用与长期手术结局并无相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba6ee38978b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969062, encodeId=2b4419690621c, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益, objectType=article, longId=738240, objectId=954ae38240b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=954ae38240b3, replyNumber=0, likeNumber=33, createdTime=2023-06-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=954ae38240b3, moduleTitle=手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=954ae38240b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969061, encodeId=1d2d196906151, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后, objectType=article, longId=734441, objectId=ecbfe3444119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecbfe3444119, replyNumber=0, likeNumber=34, createdTime=2023-06-17, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecbfe3444119, moduleTitle=J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecbfe3444119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969060, encodeId=b6f019690604e, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, objectType=article, longId=730662, objectId=e010e3066291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e010e3066291, replyNumber=0, likeNumber=35, createdTime=2023-03-04, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e010e3066291, moduleTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e010e3066291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969055, encodeId=c8fb196905547, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=IMbrave150研究结果再更新：高危肝癌患者仍获益！, objectType=article, longId=221254, objectId=f05f2212542b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05f2212542b, replyNumber=0, likeNumber=35, createdTime=2022-01-03, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05f2212542b, moduleTitle=IMbrave150研究结果再更新：高危肝癌患者仍获益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f05f2212542b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969056, encodeId=830319690568c, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Front Oncol：仑伐替尼（Lenvatinib）单药或联合PD-1抑制剂治疗中国晚期肝癌患者的疗效和安全性, objectType=article, longId=292159, objectId=2e392921592b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e392921592b, replyNumber=0, likeNumber=53, createdTime=2022-04-08, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e392921592b, moduleTitle=Front Oncol：仑伐替尼（Lenvatinib）单药或联合PD-1抑制剂治疗中国晚期肝癌患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e392921592b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969054, encodeId=defb1969054c6, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！, objectType=article, longId=218768, objectId=3150218e68f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3150218e68f5, replyNumber=0, likeNumber=44, createdTime=2022-07-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3150218e68f5, moduleTitle=J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3150218e68f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969059, encodeId=aeb41969059c6, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Clin Cancer Res：可预测晚期肝癌患者采用信迪利单抗+IBI305治疗预后的生物标志物, objectType=article, longId=723484, objectId=5c5de2348437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c5de2348437, replyNumber=0, likeNumber=43, createdTime=2022-07-15, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c5de2348437, moduleTitle=Clin Cancer Res：可预测晚期肝癌患者采用信迪利单抗+IBI305治疗预后的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c5de2348437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969051, encodeId=439919690512d, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Radiology：你听说过无接触射频消融术吗？小肝癌患者的又一选择！, objectType=article, longId=216181, objectId=d4d22161818a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4d22161818a, replyNumber=0, likeNumber=27, createdTime=2021-10-27, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4d22161818a, moduleTitle=Radiology：你听说过无接触射频消融术吗？小肝癌患者的又一选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4d22161818a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969058, encodeId=abe51969058ba, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Eur J Cancer：术后辅助立体定向放疗可改善边缘切除的肝癌患者的生存预后, objectType=article, longId=301375, objectId=297c3013e538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=297c3013e538, replyNumber=0, likeNumber=41, createdTime=2023-03-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=297c3013e538, moduleTitle=Eur J Cancer：术后辅助立体定向放疗可改善边缘切除的肝癌患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=297c3013e538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969053, encodeId=d6e5196905367, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Liver Cancer：免疫治疗期间使用抗生素会增加晚期肝癌患者的死亡率, objectType=article, longId=216587, objectId=54b321658e58, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b321658e58, replyNumber=0, likeNumber=41, createdTime=2022-01-29, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b321658e58, moduleTitle=Liver Cancer：免疫治疗期间使用抗生素会增加晚期肝癌患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b321658e58)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969057, encodeId=2459196905efc, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=祸不单行！肝癌患者全血细胞减少，竟合并了最凶险的……, objectType=article, longId=292163, objectId=acc72921631e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acc72921631e, replyNumber=0, likeNumber=61, createdTime=2022-02-08, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acc72921631e, moduleTitle=祸不单行！肝癌患者全血细胞减少，竟合并了最凶险的……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acc72921631e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969052, encodeId=a2b91969052bc, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！, objectType=article, longId=216223, objectId=1ec121622392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec121622392, replyNumber=0, likeNumber=38, createdTime=2022-01-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec121622392, moduleTitle=Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ec121622392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969047, encodeId=f07a196904e3a, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Hepatobiliary Surg Nutr：中国肝癌患者的基因突变特征！, objectType=article, longId=210644, objectId=a52321064406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52321064406, replyNumber=0, likeNumber=47, createdTime=2021-09-30, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52321064406, moduleTitle=Hepatobiliary Surg Nutr：中国肝癌患者的基因突变特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a52321064406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969049, encodeId=e5e7196904915, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Lancet oncol：阿托珠单抗联合贝伐单抗可显著改善晚期肝癌患者报告的生活质量, objectType=article, longId=211990, objectId=cb0b211990bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb0b211990bb, replyNumber=0, likeNumber=51, createdTime=2022-03-01, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb0b211990bb, moduleTitle=Lancet oncol：阿托珠单抗联合贝伐单抗可显著改善晚期肝癌患者报告的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb0b211990bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969046, encodeId=a8b2196904605, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Br J Cancer：临床研究揭示tepotinib对晚期肝癌患者的贡献, objectType=article, longId=209892, objectId=b9b320989214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b320989214, replyNumber=0, likeNumber=53, createdTime=2021-06-12, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b320989214, moduleTitle=Br J Cancer：临床研究揭示tepotinib对晚期肝癌患者的贡献, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9b320989214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969042, encodeId=4be31969042d5, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=J Hepatol：可预测肝癌患者肝移植后的存活率的风险评分方法, objectType=article, longId=205951, objectId=ca9520595100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9520595100, replyNumber=0, likeNumber=39, createdTime=2021-03-02, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9520595100, moduleTitle=J Hepatol：可预测肝癌患者肝移植后的存活率的风险评分方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9520595100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969039, encodeId=470a19690399a, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Hepatology| 肝癌患者肝移植术后结果：美国多中心队列报告, objectType=article, longId=205262, objectId=89a7205262d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89a7205262d6, replyNumber=0, likeNumber=46, createdTime=2021-11-23, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89a7205262d6, moduleTitle=Hepatology| 肝癌患者肝移植术后结果：美国多中心队列报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89a7205262d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969044, encodeId=95e5196904446, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Br J Surg：Child-Pugh B级肝硬化肝癌患者能否进行腹腔镜肝切除术？, objectType=article, longId=208423, objectId=e9c720842319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9c720842319, replyNumber=0, likeNumber=53, createdTime=2021-05-07, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9c720842319, moduleTitle=Br J Surg：Child-Pugh B级肝硬化肝癌患者能否进行腹腔镜肝切除术？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9c720842319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969048, encodeId=aa8a196904863, content=<a href='/topic/show?id=4dd7812e8f3' target=_blank style='color:#2F92EE;'>#肝癌患者#</a>, objectTitle=Liver Cancer：有脉管癌栓的晚期肝癌患者或可选择肝动脉灌注化疗+放疗！, objectType=article, longId=211441, objectId=99912114417d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99912114417d, replyNumber=0, likeNumber=35, createdTime=2022-02-13, rootId=0, userName=zhu_jun9837, userId=3609256, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99912114417d, moduleTitle=Liver Cancer：有脉管癌栓的晚期肝癌患者或可选择肝动脉灌注化疗+放疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99912114417d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝癌患者

2020-05-29

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Pain：肝癌患者术后阿片类药物使用与长期手术结局并无相关性

2023-02-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益

2023-06-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

J Clin Oncol：乐伐替尼联合经动脉化疗栓塞可显著改善晚期肝癌患者预后

2023-06-17

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性

2023-03-04

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

IMbrave150研究结果再更新：高危肝癌患者仍获益！

2022-01-03

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Front Oncol：仑伐替尼（Lenvatinib）单药或联合PD-1抑制剂治疗中国晚期肝癌患者的疗效和安全性

2022-04-08

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！

2022-07-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Clin Cancer Res：可预测晚期肝癌患者采用信迪利单抗+IBI305治疗预后的生物标志物

2022-07-15

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Radiology：你听说过无接触射频消融术吗？小肝癌患者的又一选择！

2021-10-27

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Eur J Cancer：术后辅助立体定向放疗可改善边缘切除的肝癌患者的生存预后

2023-03-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Liver Cancer：免疫治疗期间使用抗生素会增加晚期肝癌患者的死亡率

2022-01-29

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

祸不单行！肝癌患者全血细胞减少，竟合并了最凶险的……

2022-02-08

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！

2022-01-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Hepatobiliary Surg Nutr：中国肝癌患者的基因突变特征！

2021-09-30

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Lancet oncol：阿托珠单抗联合贝伐单抗可显著改善晚期肝癌患者报告的生活质量

2022-03-01

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Br J Cancer：临床研究揭示tepotinib对晚期肝癌患者的贡献

2021-06-12

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

J Hepatol：可预测肝癌患者肝移植后的存活率的风险评分方法

2021-03-02

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Hepatology| 肝癌患者肝移植术后结果：美国多中心队列报告

2021-11-23

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Br J Surg：Child-Pugh B级肝硬化肝癌患者能否进行腹腔镜肝切除术？

2021-05-07

zhu_jun9837 (审核中...)

前往app查看评论内容

#肝癌患者#

Liver Cancer：有脉管癌栓的晚期肝癌患者或可选择肝动脉灌注化疗+放疗！

2022-02-13

科室
- - 订阅+
  - 更多科室
工具
服务